aTyr Pharma | LIFE - Operating Expenses


aTyr Pharma reported $2.42M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Ardelyx USD 127.27M 7.15M Mar/2026
aTyr Pharma USD 2.42M 83.19M Mar/2026
Biogen USD 2.98B 1.02B Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Cipla INR 62.31B 3.04B Jun/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.19M 96K Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Curis USD 11.52M 2.5M Mar/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Grifols EUR 1.99B 217.4M Dec/2025
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026